Radiofrequency ablation of hepatocellular carcinoma: long-term outcome and prognostic factors
To investigate the efficacy of radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) and the prognostic factors for post-RFA survival rate. Background: Radiofrequency ablation (RFA) is a novel technique for the treatment of liver malignancies that is becoming increasingly more popular bec...
Gespeichert in:
Veröffentlicht in: | Clinical imaging 2009-01, Vol.33 (1), p.79-79 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | To investigate the efficacy of radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) and the prognostic factors for post-RFA survival rate. Background: Radiofrequency ablation (RFA) is a novel technique for the treatment of liver malignancies that is becoming increasingly more popular because of its feasibility, effectivity, repeatability, and safety. However, an increased number of complications after RFA has been reported in literature. The aim of this paper is to discuss the possible role of RFA in rapid intrahepatic spreading of hepatocellular carcinoma (HCC). Patients and methods We treated a 66-year-old woman who had a 3.5-cm HCC with two courses of percutaneous RFA using a modified needle with seven hooks. The effectiveness of the treatment was assessed 1 month later by enhanced computed tomography. Results Two courses of treatment were needed owing to the nodule position (close to the inferior vena cava). Computed tomography scan performed 1 month after the second RFA showed an intrahepatic arteriovenous fistula. Angiography performed after 1 month showed a rapid intrahepatic spreading of HCC. Conclusions Radiofrequency ablation can create an arteriovenous fistula that can facilitate migration of tumoral cells from the nodule to the hepatic portal system and rapid intrahepatic dissemination of HCC. |
---|---|
ISSN: | 0899-7071 1873-4499 |
DOI: | 10.1016/j.clinimag.2008.10.015 |